CA 19.9 - Pancreatic Cancer Marker

The CA 19.9 – Pancreatic Cancer Marker test is done to check the growth of pancreatic cancer through a blood sample. Elevated concentration of CA 19.9 may indicate pancreatic or gastrointestinal cancer. While this test alone cannot be used as the only approach to diagnosing cancer, it plays a crucial role in tracking disease response to treatment and in evaluating overall condition.

The test is done to measure the levels of the CA 19.9 antigen in the blood and  elevated glucose levels are observed in cases of severe pancreatic cancer. 

You can use this test for the following tasks:

• This test is used to monitor cancer respond to treatment and evaluating the chemotherapy affect
• Checking for cancer recurrence after surgical removal of tumors
• Helps doctors in diagnosing patients who have jaundice, abdominal pain or unusually weight loss

CA 19.9 can also increase in individuals with pancreatitis, liver cirrhosis, gallstones or hepatitis. So for detecting cancer CA 19.9 is normally used along with other tests and images.

This test is suggested to the individuals having pancreatic issues or those receiving pancreatic cancer treatment.

Schedule your appointment for  CA 19.9 – Pancreatic Cancer Marker with UniQ Pathlab and get reliable, accurate reports in a short time with direct support from our team of experts.